Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Plant based Bioavailability Enhancers

Author(s): Sweta Patel, Shruti Chopra, Simran Chaurasia and Maryam Sarwat*

Volume 28, Issue 8, 2022

Published on: 30 March, 2022

Page: [642 - 654] Pages: 13

DOI: 10.2174/1381612828666220112141355

Price: $65

Abstract

Many of the synthetic and herbal drugs, despite their notable in vitro findings, demonstrate insignificant in vivo activity, the majority of the time due to poor bioavailability. As per Biopharmaceutical Classification System (BCS), one of the main concerns is low solubility and/or permeation of drugs resulting in reduced absorption and poor bioavailability. To overcome these issues, various strategies have been adopted, including the use of permeation enhancers which are also known as bioenhancers. Bioenhancers are synthetic or natural compounds that increase the bioavailability of drugs and nutrients such as vitamins, amino acids, minerals, etc., into the systemic circulation and at the site of action for exhibiting improved therapeutic action. By improving bioavailability, bioenhancers can reduce drug dose, decrease the treatment period, and circumvent the problem of drug resistance. Although numerous studies have reported the application of synthetic bioenhancers, plant based bioenhancers can serve as a better alternative owing to their natural origin. Literature reviews have revealed that plant-based bioenhancers have been used in a wide variety of antibiotics, antiviral, and anti-cancer therapeutics. These can be categorized based on their sources and mechanism of action. This review will provide a systematic and detailed overview of the various plant based bioenhancers and their applications.

Keywords: Bioavailability, bioenhancers, solubility, permeation, pharmaceuticals, formulations.

« Previous Next »
[1]
Atal N, Bedi KL. Bioenhancers: Revolutionary concept to market. J Ayurveda Integr Med 2010; 1(2): 96-9.
[http://dx.doi.org/10.4103/0975-9476.65073] [PMID: 21836795]
[2]
Dudhatra GB, Mody SK, Awale MM, et al. A comprehensive review on pharmacotherapeutics of herbal bioenhancers Sci World J 2012; 2012.
[http://dx.doi.org/10.1100/2012/637953]
[3]
Tatiraju DV, Bagade VB, Karambelkar PJ, Jadhav VM, Kadam V. Natural bioenhancers: An overview. J Pharmacogn Phytochem 2013; 2(3): 55-60.
[4]
Patel R, Singh SK, Singh S, Sheth NR, Gendle R. Development and characterization of curcumin loaded tranfersome for tansdermal delivery. J Pharm Sci Res 2009; 1(4): 71.
[5]
Karthikeyan A, Shanthi V, Nagasathaya A. Preliminary phytochemical and antibacterial screening of crude extract of the leaf of Adhatoda vasica. L. Int J Green Pharm 2009; 3(1).
[http://dx.doi.org/10.4103/0973-8258.49381]
[6]
Nair KM, Augustine LF. Food synergies for improving bioavailability of micronutrients from plant foods. Food Chem 2018; 238: 180-5.
[http://dx.doi.org/10.1016/j.foodchem.2016.09.115] [PMID: 28867091]
[7]
Bhatia A, Singh B, Bhushan S, Katare OP. Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line. Drug Dev Ind Pharm 2010; 36(3): 350-4.
[http://dx.doi.org/10.3109/03639040903173549] [PMID: 19719395]
[8]
Singh R, Devi S, Patel J, Patel U, Bhavsar S, Thaker A. Indian herbal bioenhancers: a review. Pharmacogn Rev 2009; 3(5): 90.
[9]
Chivte VK, Tiwari SV, Nikalge APG. Bioenhancers: A brief review. Adv J Pharm Life Sci Res 2017; 2: 1-18.
[10]
Kumar-Sarangi M, Chandra-Joshi B, Ritchie B. Natural bioenhancers in drug delivery: An overview. P R Health Sci J 2018; 37(1): 12-8.
[PMID: 29547679]
[11]
Malakar J, Sen SO, Nayak AK, Sen KK. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm J 2012; 20(4): 355-63.
[http://dx.doi.org/10.1016/j.jsps.2012.02.001] [PMID: 23960810]
[12]
Singh HP, Utreja P, Tiwary AK, Jain S. Elastic liposomal formulation for sustained delivery of colchicine: in vitrocharacterization and in vivo evaluation of anti-gout activity. AAPS J 2009; 11(1): 54-64.
[http://dx.doi.org/10.1208/s12248-008-9078-8] [PMID: 19191031]
[13]
Kesarwani K, Gupta R, Mukerjee A. Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed 2013; 3(4): 253-66.
[http://dx.doi.org/10.1016/S2221-1691(13)60060-X] [PMID: 23620848]
[14]
Goyal A, Kumar S, Nagpal M, Singh I, Arora S. Potential of novel drug delivery systems for herbal drugs. Indian J Pharm Educ Res 2011; 45(3): 225-35.
[15]
Bhattacharya S. Phytosomes: the new technology for enhancement of bioavailability of botanicals and nutraceuticals. Int J Heal Res 2009; 2(3): 225-32.
[http://dx.doi.org/10.4314/ijhr.v2i3.47905]
[16]
Bhatia A, Singh B, Amarji B, Katare OP. Tamoxifen-loaded liposomal topical formulation arrests hair growth in mice. Br J Dermatol 2010; 163(2): 412-5.
[http://dx.doi.org/10.1111/j.1365-2133.2010.09772.x] [PMID: 20331445]
[17]
Liu ZQ, Zhou H, Liu L, et al. Influence of co-administrated sinomenine on pharmacokinetic fate of paeoniflorin in unrestrained conscious rats. J Ethnopharmacol 2005; 99(1): 61-7.
[http://dx.doi.org/10.1016/j.jep.2005.01.052] [PMID: 15848021]
[18]
Su YL, Fu ZY, Zhang JY, Wang WM, Wang H, Wang YC, et al. Microencapsulation of Radix salvia miltiorrhiza nanoparticles by spray-drying. Powder Technol 2008; 184(1): 114-21.
[http://dx.doi.org/10.1016/j.powtec.2007.08.014]
[19]
Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 2003; 56(2): 189-96.
[http://dx.doi.org/10.1016/S0939-6411(03)00067-5] [PMID: 12957632]
[20]
You J, Cui FD, Han X, et al. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil. Colloids Surf B Biointerfaces 2006; 48(1): 35-41.
[http://dx.doi.org/10.1016/j.colsurfb.2005.12.011] [PMID: 16480856]
[21]
El-Samaligy MS, Afifi NN, Mahmoud EA. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. Int J Pharm 2006; 319(1-2): 121-9.
[http://dx.doi.org/10.1016/j.ijpharm.2006.04.023] [PMID: 16837151]
[22]
Khubber S, Hashemifesharaki R, Mohammadi M, Gharibzahedi SMT. Garlic (Allium sativum L.): a potential unique therapeutic food rich in organosulfur and flavonoid compounds to fight with COVID-19. Nutr J 2020; 19(1): 124.
[http://dx.doi.org/10.1186/s12937-020-00643-8] [PMID: 33208167]
[23]
Annamalai AR, Manavlan RT. A bioavailability enhancer. Indian Drugs 1989; 27: 595-604.
[24]
Bajad S, Bedi KL, Singla AK, Johri RK. Piperine inhibits gastric emptying and gastrointestinal transit in rats and mice. Planta Med 2001; 67(2): 176-9.
[http://dx.doi.org/10.1055/s-2001-11505] [PMID: 11301872]
[25]
Zutshi RK, Singh R, Zutshi U, Johri RK, Atal CK. Influence of piperine on rifampicin blood levels in patients of pulmonary tuberculosis. J Assoc Physicians India 1985; 33(3): 223-4.
[PMID: 4044481]
[26]
Johri RK, Thusu N, Khajuria A, Zutshi U. Piperine-mediated changes in the permeability of rat intestinal epithelial cells. The status of γ-glutamyl transpeptidase activity, uptake of amino acids and lipid peroxidation. Biochem Pharmacol 1992; 43(7): 1401-7.
[http://dx.doi.org/10.1016/0006-2952(92)90195-O] [PMID: 1348936]
[27]
Randhawa GK, Kullar JS. Rajkumar. Bioenhancers from mother nature and their applicability in modern medicine. Int J Appl Basic Med Res 2011; 1(1): 5-10.
[http://dx.doi.org/10.4103/2229-516X.81972] [PMID: 23776764]
[28]
Reen RK, Jamwal DS, Taneja SC, et al. Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitroby piperine. Biochem Pharmacol 1993; 46(2): 229-38.
[http://dx.doi.org/10.1016/0006-2952(93)90408-O] [PMID: 8347144]
[29]
Wadhwa S, Singhal S, Rawal S. Bioavailability enhancement by piperine: a review. Asian J Biomed Pharm Sci 2014; 4(36): 1.
[30]
Gorgani L, Mohammadi M, Najafpour GD, Nikzad M. Piperine-the bioactive compound of black pepper: from isolation to medicinal formulations. Compr Rev Food Sci Food Saf 2017; 16(1): 124-40.
[http://dx.doi.org/10.1111/1541-4337.12246] [PMID: 33371546]
[31]
Choudhary N, Khajuria V, Gillani ZH, Tandon VR, Arora E. Effect of Carum carvi, a herbal bioenhancer on pharmacokinetics of antitubercular drugs: A study in healthy human volunteers. Perspect Clin Res 2014; 5(2): 80-4.
[http://dx.doi.org/10.4103/2229-3485.128027] [PMID: 24741485]
[32]
Patil UK, Singh A, Chakraborty AK. Role of piperine as a bioavailability enhancer. Int J Recent Adv Pharm Res 2011; 4: 16-23.
[33]
Chawla PC. Resorine A novel CSIR drug curtails TB treatment CSIR news 2010; 60: 52-4.
[34]
Javed S, Ahsan W, Kohli K. The concept of bioenhancers in bioavailability enhancement of drugs–a patent review. J Sci Lett 2016; 1: 143-65.
[35]
Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol 1991; 41(6): 615-7.
[http://dx.doi.org/10.1007/BF00314996] [PMID: 1815977]
[36]
Bano G, Amla V, Raina RK, Zutshi U, Chopra CL. The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Med 1987; 53(6): 568-9.
[http://dx.doi.org/10.1055/s-2006-962814] [PMID: 3444866]
[37]
Pattanaik S, Hota D, Prabhakar S, Kharbanda P, Pandhi P. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. Phytother Res 2006; 20(8): 683-6.
[http://dx.doi.org/10.1002/ptr.1937] [PMID: 16767797]
[38]
Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998; 64(4): 353-6.
[http://dx.doi.org/10.1055/s-2006-957450] [PMID: 9619120]
[39]
Pattanaik S, Hota D, Prabhakar S, Kharbanda P, Pandhi P. Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients. Phytother Res 2009; 23(9): 1281-6.
[http://dx.doi.org/10.1002/ptr.2676] [PMID: 19283724]
[40]
Johnson JJ, Nihal M, Siddiqui IA, et al. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res 2011; 55(8): 1169-76.
[http://dx.doi.org/10.1002/mnfr.201100117] [PMID: 21714124]
[41]
To H, Swarup A, Maheshwari S, Joshi PK, Kumar R, Singh N. Bioremediation of Heavy Metals in Liquid Media Through Fungi Isolated from Contaminated Sources 2011; 3: 1-10.
[42]
Jain G, Patil UK. Strategies for enhancement of bioavailability of medicinal agents with natural products. Int J Pharm Sci Res 2015; 6(12): 5315-24.
[43]
Prasad R, Singh A, Gupta N, Tarke C. Role of Bioenhancers in Tuberculosis 2016 3076.
[44]
Singh A, Verma BK, Pandey S. Exploring natural bioenhancers to enhancing bioavailability: An Overview. Int J Pharm Life Sci 2021; 12(2): 24-31.
[45]
Li X, Choi J-S. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Int J Pharm 2007; 337(1-2): 188-93.
[http://dx.doi.org/10.1016/j.ijpharm.2007.01.002] [PMID: 17267149]
[46]
Lambert JD, Kwon S-J, Ju J, et al. Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate. Carcinogenesis 2008; 29(10): 2019-24.
[http://dx.doi.org/10.1093/carcin/bgn182] [PMID: 18684728]
[47]
Qazi GN, Tikoo CL, Gupta AK, et al. Bioavailability/bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereof. United States Patent 7514105, 2003.
[48]
Chan K, Liu ZQ, Jiang ZH, et al. The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model. J Ethnopharmacol 2006; 103(3): 425-32.
[http://dx.doi.org/10.1016/j.jep.2005.08.020] [PMID: 16169700]
[49]
Johri RK. Cuminum cyminum and Carum carvi: An update. Pharmacogn Rev 2011; 5(9): 63-72.
[http://dx.doi.org/10.4103/0973-7847.79101] [PMID: 22096320]
[50]
Sachin BS, Sharma SC, Sethi S, et al. Herbal modulation of drug bioavailability: enhancement of rifampicin levels in plasma by herbal products and a flavonoid glycoside derived from Cuminum cyminum. Phytother Res 2007; 21(2): 157-63.
[http://dx.doi.org/10.1002/ptr.2046] [PMID: 17128432]
[51]
Zhang W, Tan TMC, Lim L-Y. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispos 2007; 35(1): 110-5.
[http://dx.doi.org/10.1124/dmd.106.011072] [PMID: 17050652]
[52]
Lee CK, Ki SH, Choi JS. Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin. Biopharm Drug Dispos 2011; 32(4): 245-51.
[http://dx.doi.org/10.1002/bdd.754] [PMID: 21506134]
[53]
Cho YA, Lee W, Choi JS. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin. Pharmazie 2012; 67(2): 124-30.
[PMID: 22512082]
[54]
Ching H, Tsai S-Y, Hsiu S-L, Wu P-P, Chao P-DL. Effect of curcumin on theophylline pharmacokinetics in rabbits. J Chin Med 2001; 12(1): 51-9.
[55]
Pavithra BH, Prakash N, Jayakumar K. Modification of pharmacokinetics of norfloxacin following oral administration of curcumin in rabbits. J Vet Sci 2009; 10(4): 293-7.
[http://dx.doi.org/10.4142/jvs.2009.10.4.293] [PMID: 19934593]
[56]
Basu NK, Kole L, Kubota S, Owens IS. Human UDP-glucuronosyltransferases show atypical metabolism of mycophenolic acid and inhibition by curcumin. Drug Metab Dispos 2004; 32(7): 768-73.
[http://dx.doi.org/10.1124/dmd.32.7.768] [PMID: 15205394]
[57]
Hodek P, Trefil P, Stiborová M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 2002; 139(1): 1-21.
[http://dx.doi.org/10.1016/S0009-2797(01)00285-X] [PMID: 11803026]
[58]
Lim SC, Choi JS. Effects of naringin on the pharmacokinetics of intravenous paclitaxel in rats. Biopharm Drug Dispos 2006; 27(9): 443-7.
[http://dx.doi.org/10.1002/bdd.523] [PMID: 17009338]
[59]
Kim HJ, Choi JS. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits. Biopharm Drug Dispos 2005; 26(7): 295-300.
[http://dx.doi.org/10.1002/bdd.459] [PMID: 16013069]
[60]
Yeum C-H, Choi J-S. Effect of naringin pretreatment on bioavailability of verapamil in rabbits. Arch Pharm Res 2006; 29(1): 102-7.
[http://dx.doi.org/10.1007/BF02977476] [PMID: 16491851]
[61]
de Castro WV, Mertens-Talcott S, Derendorf H, Butterweck V. Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats. J Agric Food Chem 2008; 56(12): 4840-5.
[http://dx.doi.org/10.1021/jf0728451] [PMID: 18494494]
[62]
Meher B. Importance of some herbal bioenhancers in modern Medicine. World J Pharm Pharm Sci 2016; 5(12): 1605-15.
[63]
Park HS, Oh J-H. Lee Jh, Lee Y-J. Minor effects of the citrus flavonoids naringin, naringenin and quercetin, on the pharmacokinetics of doxorubicin in rats. Pharmazie 2011; 66(6): 424-9.
[PMID: 21699081]
[64]
Choi JS, Han HK. The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits. J Pharm Pharmacol 2004; 56(12): 1537-42.
[http://dx.doi.org/10.1211/0022357044814] [PMID: 15563760]
[65]
Choi J-S, Li X. Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits. Int J Pharm 2005; 297(1-2): 1-8.
[http://dx.doi.org/10.1016/j.ijpharm.2004.12.004] [PMID: 15907592]
[66]
Shin S-C, Choi J-S, Li X. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats. Int J Pharm 2006; 313(1-2): 144-9.
[http://dx.doi.org/10.1016/j.ijpharm.2006.01.028] [PMID: 16516418]
[67]
Li X, Choi J-S. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats. Anticancer Res 2009; 29(4): 1411-5.
[PMID: 19414395]
[68]
Kale A, Gawande S, Kotwal S, et al. Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract. Phytother Res 2010; 24(S1)(Suppl. 1): S48-55.
[http://dx.doi.org/10.1002/ptr.2899] [PMID: 19585479]
[69]
Umathe SN, Dixit PV, Kumar V, Bansod KU, Wanjari MM. Quercetin pretreatment increases the bioavailability of pioglitazone in rats: involvement of CYP3A inhibition. Biochem Pharmacol 2008; 75(8): 1670-6.
[http://dx.doi.org/10.1016/j.bcp.2008.01.010] [PMID: 18329630]
[70]
Kim K-A, Park P-W, Park J-Y. Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers. Eur J Clin Pharmacol 2009; 65(6): 609-14.
[http://dx.doi.org/10.1007/s00228-009-0627-6] [PMID: 19221726]
[71]
Xiao J, Huang W-H, Peng J-B, Tan Z-R, Ou-Yang D-S, Hu D-L, et al. Quercetin significantly inhibits the metabolism of caffeine, a substrate of cytochrome P450 1A2 unrelated to CYP1A2* 1C (− 2964G> A) and* 1F (734C> A) gene polymorphisms. Biomed Res Int 2014; 2014.
[72]
Dupuy J, Larrieu G, Sutra JF, Lespine A, Alvinerie M. Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Vet Parasitol 2003; 112(4): 337-47.
[http://dx.doi.org/10.1016/S0304-4017(03)00008-6] [PMID: 12623212]
[73]
Choi J-S, Piao Y-J, Kang KW. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin. Arch Pharm Res 2011; 34(4): 607-13.
[http://dx.doi.org/10.1007/s12272-011-0411-x] [PMID: 21544726]
[74]
Hsiu S-L, Hou Y-C, Wang Y-H, Tsao C-W, Su S-F, Chao P-DL. Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats. Life Sci 2002; 72(3): 227-35.
[http://dx.doi.org/10.1016/S0024-3205(02)02235-X] [PMID: 12427482]
[75]
Wang Y-H, Chao P-DL, Hsiu S-L, Wen K-C, Hou Y-C. Lethal quercetin-digoxin interaction in pigs. Life Sci 2004; 74(10): 1191-7.
[http://dx.doi.org/10.1016/j.lfs.2003.06.044] [PMID: 14697403]
[76]
Zhao J-Q, Du G-Z, Xiong Y-C, Wen Y-F, Bhadauria M, Nirala SK. Attenuation of beryllium induced hepatorenal dysfunction and oxidative stress in rodents by combined effect of gallic acid and piperine. Arch Pharm Res 2007; 30(12): 1575-83.
[http://dx.doi.org/10.1007/BF02977327] [PMID: 18254245]
[77]
Wacher VJ, Benet LZ. Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds Google Patents 2001.
[78]
Wacher VJ, Wong S, Wong HT. Peppermint oil enhances cyclosporine oral bioavailability in rats: comparison with D-α-tocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole. J Pharm Sci 2002; 91(1): 77-90.
[http://dx.doi.org/10.1002/jps.10008] [PMID: 11782899]
[79]
Li C, Choi JS. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats. Pharmazie 2008; 63(11): 815-8.
[PMID: 19069242]
[80]
Shin S-C, Piao Y-J, Choi J-S. Effects of morin on the bioavailability of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. in vivo (Brooklyn) 2008; 22(3): 391-5.
[81]
Zhang S, Morris ME. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J Pharmacol Exp Ther 2003; 304(3): 1258-67.
[http://dx.doi.org/10.1124/jpet.102.044412] [PMID: 12604704]
[82]
Kim C-S, Choi S-J, Park C-Y, Li C, Choi J-S. Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats. Anticancer Res 2010; 30(1): 79-85.
[PMID: 20150620]
[83]
Javed S, Ahsan W, Kohli K. Pharmacological influences of natural products as bioenhancers of silymarin against carbon tetrachloride-induced hepatotoxicity in rats. Clin Phytoscience 2018; 4(1): 1-9.
[http://dx.doi.org/10.1186/s40816-018-0079-6]
[84]
Vinson JA, Al Kharrat H, Andreoli L. Effect of Aloe vera preparations on the human bioavailability of vitamins C and E. Phytomedicine 2005; 12(10): 760-5.
[http://dx.doi.org/10.1016/j.phymed.2003.12.013] [PMID: 16323295]
[85]
Beneke C, Viljoen A, Hamman J. in vitrodrug absorption enhancement effects of Aloe vera and Aloe ferox. Sci Pharm 2012; 80(2): 475-86.
[http://dx.doi.org/10.3797/scipharm.1202-10] [PMID: 22896832]
[86]
Pathak N. Role of Bioenhancers in Drug Discovery. Int J Pharm Life Sci 2020; 11(7): 51.
[87]
Shobha KS, Gurucharan DN. Glycyrrhizin glabra as a bioenhancer for antibiotics 2014.
[88]
Nduka SO, Adonu LZ, Okonta EO, Okonta JM. The influence of ginger (Zingiber officinale) extract on the pharmacokinetic profile of pefloxacin. Inter J Appl Res Nat Pdt 2013; 6(2): 15-8.
[89]
Ogita A, Fujita K, Taniguchi M, Tanaka T. Enhancement of the fungicidal activity of amphotericin B by allicin, an allyl-sulfur compound from garlic, against the yeast Saccharomyces cerevisiae as a model system. Planta Med 2006; 72(13): 1247-50.
[http://dx.doi.org/10.1055/s-2006-947203] [PMID: 16902870]
[90]
Borjihan H, Ogita A, Fujita K, Hirasawa E, Tanaka T. The vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans and its enhancement by allicin. J Antibiot (Tokyo) 2009; 62(12): 691-7.
[http://dx.doi.org/10.1038/ja.2009.103] [PMID: 19876074]
[91]
Gokaraju GR, Gokaraju RR, D’souza C, Frank E. Bioavailability/ bio-efficacy enhancing activity of Stevia rebaudiana and extracts and fractions and compounds thereof 2010.
[92]
Bouraoui A, Toumi A, Ben Mustapha H, Brazier JL. Effects of capsicum fruit on theophylline absorption and bioavailability in rabbits. Drug Nutr Interact 1988; 5(4): 345-50.
[PMID: 3240714]
[93]
Bouraoui A, Brazier JL, Zouaghi H, Rousseau M. Theophylline pharmacokinetics and metabolism in rabbits following single and repeated administration of Capsicum fruit. Eur J Drug Metab Pharmacokinet 1995; 20(3): 173-8.
[http://dx.doi.org/10.1007/BF03189666] [PMID: 8751037]
[94]
Cruz L, Castañeda-Hernández G, Navarrete A. Ingestion of chilli pepper (Capsicum annuum) reduces salicylate bioavailability after oral asprin administration in the rat. Can J Physiol Pharmacol 1999; 77(6): 441-6.
[http://dx.doi.org/10.1139/y99-032] [PMID: 10537230]
[95]
Zafar N. Herbal bioenhancers: A revolutionary concept in modern medicine. World J Pharmaceut Res 2017; 6(16): 381-97.
[96]
Upadhyay HC, Dwivedi GR, Darokar MP, Chaturvedi V, Srivastava SK. Bioenhancing and antimycobacterial agents from Ammannia multiflora. Planta Med 2012; 78(1): 79-81.
[http://dx.doi.org/10.1055/s-0031-1280256] [PMID: 21969115]
[97]
Ajazuddin Alexander A. Qureshi A, et al. Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients. Fitoterapia 2014; 97: 1-14.
[http://dx.doi.org/10.1016/j.fitote.2014.05.005] [PMID: 24862064]
[98]
Shukla M, Malik MY, Jaiswal S, Sharma A, Tanpula DK, Goyani R, et al. A mechanistic investigation of the bioavailability enhancing potential of lysergol, a novel bioenhancer, using curcumin. RSC Advances 2016; 6(64): 58933-42.
[http://dx.doi.org/10.1039/C6RA09307H]
[99]
Patil S, Dash RP, Anandjiwala S, Nivsarkar M. Simultaneous quantification of berberine and lysergol by HPLC-UV: evidence that lysergol enhances the oral bioavailability of berberine in rats. Biomed Chromatogr 2012; 26(10): 1170-5.
[http://dx.doi.org/10.1002/bmc.2674] [PMID: 22213237]
[100]
Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014; 4: 177.
[http://dx.doi.org/10.3389/fphar.2013.00177] [PMID: 24454289]
[101]
Msomi NZ, Simelane MBC. Herbal Medicine. Rijeka: IntechOpen 2019.
[http://dx.doi.org/10.5772/intechopen.72816]
[102]
Zhang J, Wider B, Shang H, Li X, Ernst E. Quality of herbal medicines: challenges and solutions. Complement Ther Med 2012; 20(1-2): 100-6.
[http://dx.doi.org/10.1016/j.ctim.2011.09.004] [PMID: 22305255]
[103]
Lehner R, Wang X, Marsch S, Hunziker P. Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application. Nanomedicine 2013; 9(6): 742-57.
[http://dx.doi.org/10.1016/j.nano.2013.01.012] [PMID: 23434677]
[104]
Moshawih S, Cheema MS, Ahmad Z, Zakaria ZA, Hakim MN. A comprehensive review on Cosmos caudatus (Ulam raja): pharmacology, ethnopharmacology, and phytochemistry. Int Res J Educ Sci 2017; 1(1): 14-31.
[105]
Dekkers OM, Vandenbroucke JP, Cevallos M, Renehan AG, Altman DG, Egger M. COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology. PLoS Med 2019; 16(2)e1002742
[http://dx.doi.org/10.1371/journal.pmed.1002742] [PMID: 30789892]
[106]
Hay SI, Abajobir AA, Abate KH, et al. GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390(10100): 1260-344.
[http://dx.doi.org/10.1016/S0140-6736(17)32130-X] [PMID: 28919118]
[107]
Kapoor S, Saraf S. Efficacy study of sunscreens containing various herbs for protecting skin from UVA and UVB sunrays. Pharmacogn Mag 2009; 5(19): 238.
[108]
Buso P, Radice M, Baldisserotto A, Manfredini S, Vertuani S. Guidelines for the development of herbal-based sunscreen. Herbal Medicine. IntechOpen 2017.
[109]
Sharma S. Current status of herbal product: Regulatory overview. J Pharm Bioallied Sci 2015; 7(4): 293-6.
[http://dx.doi.org/10.4103/0975-7406.168030] [PMID: 26681886]
[110]
Shaji J, Lal M. Preparation, optimization and evaluation of transferosomal formulation for enhanced transdermal delivery of a COX-2 inhibitor. Int J Pharm Pharm Sci 2014; 6(1): 467-77.
[111]
Vaidya ADB, Devasagayam TPA. Current status of herbal drugs in India: an overview. J Clin Biochem Nutr 2007; 41(1): 1-11.
[http://dx.doi.org/10.3164/jcbn.2007001] [PMID: 18392106]

Rights & Permissions Print Cite
Article Metrics
26
1
© 2024 Bentham Science Publishers | Privacy Policy